MeSH tree: C12.200.758.409
Researchers have identified 22 pesticides consistently associated with the incidence of prostate cancer in the United States, with four of the pesticides also linked with prostate cancer mortality. The findings are published ...
Nov 4, 2024
0
140
Although much rarer than either breast or prostate cancers, testicular cancer is the most common solid tumor in males between the ages of 15 and 35, with approximately 10,000 young men diagnosed annually in the United States.
Oct 31, 2024
0
20
A team of molecular biologists and other medical specialists at Cold Spring Harbor Laboratory in New York, working with a large number of international partners, reports evidence that a synthetic vitamin K precursor can be ...
Researchers at The University of Texas at El Paso have created a portable device that can detect colorectal and prostate cancer more cheaply and quickly than prevailing methods. The team believes the device may be especially ...
Oct 24, 2024
0
650
Stereotactic body radiotherapy (SBRT) is noninferior to conventional or moderately fractionated radiotherapy for localized prostate cancer (PC), according to a study published online Oct. 16 in the New England Journal of ...
Oct 17, 2024
0
25
In a study believed to be the first of its kind published, a research team led by Johns Hopkins Medicine provides scientific evidence that a healthy diet may reduce the chance of low risk prostate cancer progressing to a ...
Oct 17, 2024
0
63
A team at the University of Cordoba and IMIBIC tested the protective effect of a fermented black garlic extract against inflammation and the progression of prostate cancer in a study conducted on human prostate cancer cell ...
Oct 15, 2024
0
42
Researchers have identified the genetic risk factors that contribute to prostate cancer in a diverse group of African men. Although research and treatment are scant, this first large-scale African genomics study could signal ...
Oct 10, 2024
0
33
Every year, over 1.5 million new cases of prostate cancer are diagnosed throughout the world. As one of the leading causes of death for men in multiple countries, understanding the risk factors for prostate cancer has become ...
Oct 8, 2024
0
53
A recent analysis, published in The Lancet Oncology, calculates that increasing access to [¹⁷⁷Lu]PSMA therapy for eligible patients could generate $725 million in economic potential. This impact is projected across nine selected ...
Sep 30, 2024
0
61
